HCA

HCA Healthcare
D

HCA

Arincen59/100B

HCA Healthcare operating income 1990–2026

HCA Healthcare's operating income in Q3 FY2026, the three months to 30 September 2026, was 2.96B USD, down 0.0% on the same quarter a year before. HCA Healthcare's operating income over the last twelve months was 12.07B USD, up 3.8% on the twelve months before. In fiscal year 2025 it was 11.97B USD, up 13.4% on the year before.

Last updated 7 Nov 2026 · Next report 26 Jan 2027

Operating income

Operating income · +7.2% a year over 10 yearsOperating margin

Growth

Fiscal yearPeriod endingOperating incomeGrowthOperating marginGross profitGross marginEBITDA
TTM30 Sept 202612.07B+3.77%15.34%17.07B21.69%15.90B
FY202531 Dec 202511.97B+13.44%15.83%31.37B41.50%15.60B
FY202431 Dec 202410.55B+9.56%14.94%28.68B40.62%13.90B
FY202331 Dec 20239.63B+6.34%14.82%25.58B39.37%12.72B
FY202231 Dec 20229.05B-6.46%15.03%23.18B38.48%13.29B
FY202131 Dec 20219.68B+33.27%16.47%22.49B38.28%14.25B
FY202031 Dec 20207.26B+0.61%14.09%43.16B83.76%9.74B
FY201931 Dec 20197.22B+8.67%14.06%42.86B83.48%9.66B
FY201831 Dec 20186.64B+9.66%14.23%38.95B83.45%9.37B
FY201731 Dec 20176.06B-2.27%13.89%36.30B83.23%8.20B
FY201631 Dec 20166.20B+3.91%14.94%34.56B83.29%8.48B
FY201531 Dec 20155.97B+7.19%15.03%33.04B83.27%7.53B
FY201431 Dec 20145.57B+16.13%15.07%30.66B83.04%7.04B
FY201331 Dec 20134.79B-0.50%14.02%28.21B82.53%6.55B
FY201231 Dec 20124.82B+11.02%14.59%27.30B82.68%6.37B
FY201131 Dec 20114.34B+4.15%13.35%24.50B75.38%7.06B
FY201031 Dec 20104.17B+9.58%13.57%23.07B75.20%5.75B
FY200931 Dec 20093.80B+29.51%12.65%25.18B83.80%5.41B
FY200831 Dec 20082.94B-0.58%10.34%23.75B83.72%4.61B
FY200731 Dec 20072.95B+4.09%10.99%22.46B83.64%4.83B
FY200631 Dec 20062.84B-2.34%11.13%21.16B83.04%4.01B
FY200531 Dec 20052.90B+6.92%11.87%20.33B83.13%4.18B
FY200431 Dec 20042.72B-2.90%11.56%19.60B83.40%3.79B
FY200331 Dec 20032.80B+36.51%12.83%0.000.00%4.04B
FY200231 Dec 20022.05B-7.91%10.39%0.000.00%3.08B
FY200131 Dec 20012.23B-86.56%12.39%0.000.00%3.29B
FY200031 Dec 200016.55B+0.71%99.30%0.000.00%17.59B
FY199931 Dec 199916.44B-2.69%98.68%0.000.00%17.53B
FY199831 Dec 199816.89B+1,342.53%90.42%0.000.00%18.68B
FY199731 Dec 19971.17B-59.59%6.22%0.000.00%2.85B
FY199631 Dec 19962.90B+9.61%14.56%11.25B56.49%4.04B
FY199531 Dec 19952.64B+75.33%14.94%10.40B58.77%3.62B
FY199431 Dec 19941.51B+8.96%13.55%0.000.00%2.12B
FY199331 Dec 19931.38B+3,292.16%13.50%6.74B65.74%1.98B
FY199231 Dec 199240.80M+106.06%5.36%531.10M69.73%79.10M
FY199131 Dec 199119.80M+15.12%4.30%325.70M70.65%42.30M
FY199031 Dec 199017.20M—6.31%191.30M70.18%29.10M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Shares outstanding,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about HCA Healthcare's operating income

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.